NRI is excited to share these clinically relevant results for the efficacy and safety of Exenatide plus Dapagliflozin for patients with uncontrolled type 2 diabetes taking Metformin. We are proud to focus on diseases that affect our community and see great results such as these!

https://care.diabetesjournals.org/content/43/10/2528.long